U.S. markets closed

Maravai LifeSciences Holdings, Inc. (MRVI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
31.29+1.09 (+3.61%)
At close: 4:00PM EST

31.02 -0.27 (-0.86%)
After hours: 5:18PM EST

Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2019
12/31/2018
Total Revenue
221,705
143,140
123,833
Cost of Revenue
74,084
66,849
60,765
Gross Profit
147,621
76,291
63,068
Operating Expense
57,678
52,303
46,632
Operating Income
89,943
23,988
16,436
Net Non Operating Interest Income Expense
-29,653
-29,959
-27,399
Other Income Expense
155
118
-5,535
Pretax Income
60,445
-5,853
-16,498
Tax Provision
1,551
-652
417
Net Income Common Stockholders
58,371
-4,470
-4,472
Diluted NI Available to Com Stockholders
58,371
-4,470
-4,472
Basic EPS
-
0
0
Diluted EPS
-
0
0
Basic Average Shares
-
257,621
257,621
Diluted Average Shares
-
257,621
257,621
Total Operating Income as Reported
89,943
23,988
16,436
Total Expenses
131,762
119,152
107,397
Net Income from Continuing & Discontinued Operation
58,371
-4,470
-4,472
Normalized Income
58,371
-4,470
-367.94
Interest Expense
29,653
29,959
27,399
Net Interest Income
-29,653
-29,959
-27,399
EBIT
90,098
24,106
10,901
EBITDA
116,645
-
-
Reconciled Cost of Revenue
74,084
66,849
60,765
Reconciled Depreciation
26,547
24,084
22,347
Net Income from Continuing Operation Net Minority Interest
58,371
-4,470
-4,472
Total Unusual Items Excluding Goodwill
-
0
-5,622
Total Unusual Items
-
0
-5,622
Normalized EBITDA
116,645
48,190
38,870
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
-1,518